V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194177 | 20124522 | 1.59 | 77 | null | 2021-07-22 | 2021-07-31 | Gemcitabine + Capecitabine | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100858666 |
| 20194186 | 20124523 | null | 82.8 | Palliative (P) | 2019-12-14 | 2019-12-14 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100183652 |
| 20194188 | 20124524 | 1.68 | 61.7 | null | 2019-03-23 | 2019-04-03 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101559109 |
| 20194189 | 20124525 | null | 93.9 | Palliative (P) | 2019-09-14 | 2019-10-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100838432 |
| 20194192 | 20124526 | 1.84 | 73.9 | Palliative (P) | 2019-06-17 | 2019-06-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101406494 |
| 20194197 | 20124527 | 1.82 | 76.3 | null | 2021-02-13 | 2021-02-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101334448 |
| 20194198 | 20124528 | 1.65 | 65 | Palliative (P) | 2017-08-03 | 2017-08-18 | CAPECITABINE + GEMCITABINE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100111422 |
| 20194202 | 20124529 | 1.7 | 59.8 | Palliative (P) | 2019-01-05 | 2019-01-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101425085 |
| 20194208 | 20124530 | 1.59 | 63.6 | null | 2019-01-03 | 2019-01-19 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101340270 |
| 20194215 | 20124531 | 1.67 | 35.8 | 03 | 2018-08-23 | 2019-02-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100445595 |
| 20194216 | 20124532 | 1.63 | 54.2 | Neo-adjuvant (N) | 2018-09-21 | 2019-03-10 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101250157 |
| 20194226 | 20124533 | 1.68 | 72.2 | Palliative (P) | 2016-06-13 | 2016-07-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101104661 |
| 20194227 | 20124534 | 1.84 | 86.9 | Palliative (P) | 2019-04-16 | 2019-04-23 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100869771 |
| 20194228 | 20124535 | 1.96 | 44.8 | Palliative (P) | 2016-10-22 | 2016-11-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100983366 |
| 20194229 | 20124536 | 1.69 | 55.8 | Palliative (P) | null | 2016-12-30 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100569359 |
| 20194231 | 20124537 | 1.61 | 79.1 | Palliative (P) | 2015-08-30 | 2016-09-26 | Docetaxel | 02 | N | DOCETAXEL | 100680129 |
| 20194238 | 20124538 | 1.85 | 74.8 | Palliative (P) | 2018-07-04 | 2018-07-04 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101050500 |
| 20194241 | 20124539 | 1.74 | 70 | 03 | 2019-02-25 | 2019-03-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101123203 |
| 20194244 | 20124540 | 1.83 | 51 | Palliative (P) | 2017-08-19 | 2017-08-19 | Docetaxel | 02 | N | DOCETAXEL | 101199185 |
| 20194248 | 20124541 | 1.75 | 46.2 | null | 2016-08-05 | 2016-08-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101763766 |
| 20194254 | 20124542 | 1.78 | 80 | null | 2020-02-26 | 2020-02-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100072288 |
| 20194256 | 20124543 | 1.6 | 73.9 | Palliative (P) | 2017-03-30 | 2017-04-27 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | DOCETAXEL | 100611131 |
| 20194262 | 20124544 | 1.65 | 57.4 | Neo-adjuvant (N) | 2018-11-04 | 2019-05-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101206447 |
| 20194272 | 20124545 | 1.88 | 50.3 | null | 2017-04-26 | 2017-04-27 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100816827 |
| 20194279 | 20124546 | 1.63 | 69.1 | Palliative (P) | 2020-06-29 | 2020-07-20 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100031605 |
| 20194285 | 20124547 | 1.83 | 99.8 | Palliative (P) | 2018-11-14 | 2018-11-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101026487 |
| 20194288 | 20124548 | 1.83 | 76.4 | Palliative (P) | 2016-03-19 | 2016-08-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101706486 |
| 20194289 | 20124549 | 1.84 | 74.4 | Palliative (P) | 2018-03-07 | 2018-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101509185 |
| 20194298 | 20124550 | 1.63 | 77 | Neo-adjuvant (N) | 2019-03-12 | 2019-03-18 | Cetuximab + FLUOROURACIL + IRINOTECAN | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101513817 |
| 20194299 | 20124551 | 1.76 | 82 | Palliative (P) | 2018-06-04 | 2018-06-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101360416 |
| 20194300 | 20124552 | 1.74 | 82.35 | null | 2019-10-02 | 2019-10-31 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101503006 |
| 20194304 | 20124553 | 1.83 | 106 | Adjuvant (A) | 2017-12-09 | 2017-12-14 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100299424 |
| 20194305 | 20124554 | 2 | 77.65 | Palliative (P) | 2018-02-02 | 2020-03-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100145111 |
| 20194306 | 20124555 | 1.61 | 81 | null | 2017-02-08 | 2018-03-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100798104 |
| 20194310 | 20124556 | 1.7 | 60.3 | null | 2018-09-02 | 2018-09-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101853991 |
| 20194311 | 20124557 | 1.67 | 86.9 | null | 2016-01-09 | 2016-04-03 | Docetaxel | N | null | DOCETAXEL | 100986108 |
| 20194314 | 20124558 | 1.84 | 69.8 | null | 2020-03-18 | 2020-04-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101080558 |
| 20194324 | 20124559 | null | 77.6 | null | 2020-03-07 | 2020-03-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100654980 |
| 20194333 | 20124560 | 1.6 | 59.4 | Palliative (P) | 2017-04-21 | 2017-06-11 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101363448 |
| 20194339 | 20124561 | 1.59 | 58.5 | null | 2016-10-07 | 2016-10-28 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100737517 |
| 20194342 | 20124562 | 0 | 83.9 | Palliative (P) | 2018-08-17 | 2018-08-28 | CETUXIMAB + IRINOTECAN + MDG | N | N | CAPECITABINE + GEMCITABINE | 101737913 |
| 20194344 | 20124563 | 1.67 | 81 | Palliative (P) | 2016-07-20 | 2016-07-21 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101642243 |
| 20194350 | 20124564 | 1.79 | 67.5 | Adjuvant (A) | 2018-09-14 | 2018-11-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100108683 |
| 20194357 | 20124565 | 1.87 | 114.5 | Palliative (P) | 2018-05-14 | 2018-05-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101569422 |
| 20194358 | 20124566 | 1.5 | 65.8 | Adjuvant (A) | 2020-02-14 | 2020-03-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101517717 |
| 20194359 | 20124567 | 1.7 | 71.4 | Neo-adjuvant (N) | 2018-07-23 | 2018-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100910122 |
| 20194361 | 20124568 | 1.91 | 64.95 | Palliative (P) | 2018-05-04 | 2018-05-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100146411 |
| 20194363 | 20124569 | 1.83 | 68 | Palliative (P) | 2018-12-31 | 2019-01-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100155619 |
| 20194364 | 20124570 | 1.67 | 79.1 | Palliative (P) | 2016-03-18 | 2016-03-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101361772 |
| 20194365 | 20124571 | 1.51 | 99.3 | Neo-adjuvant (N) | 2017-01-14 | 2017-01-14 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101393237 |